Publication | Open Access
Capecitabine plus oxaliplatin for the first‐line treatment of elderly patients with metastatic colorectal carcinoma
91
Citations
28
References
2005
Year
Fit elderly patients with MCC showed a good RR to XELOX with only mild toxicity observed in most patients. XELOX, should, therefore be considered as an important therapeutic option for elderly patients with MCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1